Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial
Ian R. Kleckner(University of Maryland, College Park), Karen M. Mustian(University of Rochester Medical Center), Charles Kamen(University of Rochester), Charles E. Heckler(University of Rochester Medicine), Joseph J. Guido(Seagen (Canada)), Chunkit Fung(Oslo University Hospital), Michelle C. Janelsins(University of Rochester), Eva Culakova(University of Rochester), Adedayo A. Onitilo(Marshfield Clinic Weston Center), J. Philip Kuebler(Columbus Oncology and Hematology Associates), Calvin L. Cole(University of Rochester Medicine), Alison Conlin(Providence Portland Medical Center), Supriya G. Mohile(University of Rochester Medical Center)
Cited by 51
Related Papers
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer
|JAMA Oncology|2016|721
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
|Journal of Clinical Oncology|2020|556
Applied Discriminant Analysis
|Technometrics|1995|409